Annual Working Capital
$531.27 M
-$127.75 M-19.38%
31 December 2023
Summary:
Amneal Pharmaceuticals annual working capital is currently $531.27 million, with the most recent change of -$127.75 million (-19.38%) on 31 December 2023. During the last 3 years, it has fallen by -$343.37 million (-39.26%). AMRX annual working capital is now -39.26% below its all-time high of $874.64 million, reached on 31 December 2020.AMRX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$418.08 M
+$46.96 M+12.65%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly working capital is currently $418.08 million, with the most recent change of +$46.96 million (+12.65%) on 30 September 2024. Over the past year, it has dropped by -$277.39 million (-39.88%). AMRX quarterly working capital is now -54.70% below its all-time high of $922.88 million, reached on 31 March 2021.AMRX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.4% | -39.9% |
| 3 y3 years | -39.3% | -53.7% |
| 5 y5 years | -27.5% | -37.7% |
AMRX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -39.3% | at low | -53.7% | +12.7% |
| 5 y | 5 years | -39.3% | at low | -54.7% | +12.7% |
| alltime | all time | -39.3% | +11.8% | -54.7% | +12.7% |
Amneal Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $418.08 M(+12.7%) |
| June 2024 | - | $371.13 M(-32.0%) |
| Mar 2024 | - | $545.66 M(+2.7%) |
| Dec 2023 | $531.27 M(-19.4%) | $531.27 M(-23.6%) |
| Sept 2023 | - | $695.47 M(+7.9%) |
| June 2023 | - | $644.44 M(+6.8%) |
| Mar 2023 | - | $603.62 M(-8.4%) |
| Dec 2022 | $659.02 M(-21.8%) | $659.02 M(+9.5%) |
| Sept 2022 | - | $601.84 M(+7.4%) |
| June 2022 | - | $560.54 M(-28.8%) |
| Mar 2022 | - | $787.63 M(-6.6%) |
| Dec 2021 | $842.87 M | $842.87 M(-6.7%) |
| Sept 2021 | - | $903.00 M(+1.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $890.61 M(-3.5%) |
| Mar 2021 | - | $922.88 M(+5.5%) |
| Dec 2020 | $874.64 M(+32.6%) | $874.64 M(-0.1%) |
| Sept 2020 | - | $875.83 M(+6.1%) |
| June 2020 | - | $825.86 M(+2.1%) |
| Mar 2020 | - | $808.63 M(+22.6%) |
| Dec 2019 | $659.80 M(-10.0%) | $659.80 M(-1.7%) |
| Sept 2019 | - | $670.92 M(+4.9%) |
| June 2019 | - | $639.69 M(-4.3%) |
| Mar 2019 | - | $668.44 M(-8.8%) |
| Dec 2018 | $732.79 M(+54.3%) | $732.79 M(+7.4%) |
| Sept 2018 | - | $682.03 M(+0.6%) |
| June 2018 | - | $678.16 M(+42.8%) |
| Dec 2017 | $475.05 M | $475.05 M |
FAQ
- What is Amneal Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual working capital year-on-year change?
- What is Amneal Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly working capital year-on-year change?
What is Amneal Pharmaceuticals annual working capital?
The current annual working capital of AMRX is $531.27 M
What is the all time high annual working capital for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual working capital is $874.64 M
What is Amneal Pharmaceuticals annual working capital year-on-year change?
Over the past year, AMRX annual working capital has changed by -$127.75 M (-19.38%)
What is Amneal Pharmaceuticals quarterly working capital?
The current quarterly working capital of AMRX is $418.08 M
What is the all time high quarterly working capital for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly working capital is $922.88 M
What is Amneal Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, AMRX quarterly working capital has changed by -$277.39 M (-39.88%)